These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5608602)

  • 21. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
    Danysz A
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321
    [No Abstract]   [Full Text] [Related]  

  • 22. [Education in pharmacy].
    Gallo U
    Boll Chim Farm; 1967 Apr; 106(4):206-14. PubMed ID: 5613015
    [No Abstract]   [Full Text] [Related]  

  • 23. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 24. [For the sake of quality].
    Pijpers A
    Tijdschr Diergeneeskd; 1994 Aug; 119(14-15):432-8. PubMed ID: 8066580
    [No Abstract]   [Full Text] [Related]  

  • 25. The future of cosmeceuticals: an interview with Albert Kligman, MD, PhD. Interview by Zoe Diana Draelos.
    Kligman A
    Dermatol Surg; 2005 Jul; 31(7 Pt 2):890-1. PubMed ID: 16029684
    [No Abstract]   [Full Text] [Related]  

  • 26. The cosmetic/drug dilemma: FDA regulation of alpha-hydroxy acids.
    Heymann LA
    Food Drug Law J; 1997; 52(4):357-75. PubMed ID: 10346670
    [No Abstract]   [Full Text] [Related]  

  • 27. The Food and Drugs Act and quality assurance of pharmaceutical products.
    Allmark MG
    Med Serv J Can; 1967 Mar; 23(3):210-6. PubMed ID: 6056366
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bacteriological index of soft drinks and mineral water sold in Genoa].
    Guarguaglini M
    G Ig Med Prev; 1967; 8(3):354-61. PubMed ID: 5614927
    [No Abstract]   [Full Text] [Related]  

  • 29. [The birth of new drugs].
    Petrányi G
    Orv Hetil; 1968 May; 109(21):Suppl:1-6. PubMed ID: 5720715
    [No Abstract]   [Full Text] [Related]  

  • 30. [Warranty regulation on drugs].
    Christoph KH
    Pharm Prax; 1967 Oct; 10():285-8. PubMed ID: 5633432
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibiotics standards versus standards for other drugs.
    Wright WW
    Am J Hosp Pharm; 1982 Jun; 39(6):1046-7. PubMed ID: 7102691
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug safety in theory and practice.
    Friebel H
    WHO Chron; 1973 Feb; 27(2):59-65. PubMed ID: 4695972
    [No Abstract]   [Full Text] [Related]  

  • 33. [3 new laws for control of medical biology laboratories, cosmetic products and veterinary drugs].
    Bachet MC
    Rev Prat; 1975 Sep; 25(38):2971-3. PubMed ID: 1166248
    [No Abstract]   [Full Text] [Related]  

  • 34. [Registration of animal drugs].
    Abrahams CG; Bax CD
    Tijdschr Diergeneeskd; 1991 Apr; 116(7):371-3. PubMed ID: 2031243
    [No Abstract]   [Full Text] [Related]  

  • 35. [Is the testing of drugs satisfactory?].
    Kohlhaas M
    Munch Med Wochenschr; 1970 Dec; 112(49):2224-6. PubMed ID: 5536811
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulatory agencies, manufacturers and scientists in assurance of quality drugs.
    Higuchi T
    Med Serv J Can; 1967 Mar; 23(3):381-6. PubMed ID: 6056381
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drugs and their safety as secured by legal regulations from the aspect of the society at large].
    Kostka V; Solich J
    Cesk Zdrav; 1986 Sep; 34(8-9):360-3. PubMed ID: 3769040
    [No Abstract]   [Full Text] [Related]  

  • 38. [Theoretical and practical aspects of statistic sampling and related norms of acceptance].
    Mattei A; Pietra E
    Boll Chim Farm; 1968 May; 107(5):287-95. PubMed ID: 5721540
    [No Abstract]   [Full Text] [Related]  

  • 39. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 40. Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussion.
    Palylyk-Colwell E; Jamali F; Dryden W; Friesen E; Koven S; Mohamed I; Osmond B; Alessi-Severini S; Sheldon L; Sheldon R; Tam Y; Tsuyuki R; Zhanel G
    J Pharm Pharm Sci; 1998; 1(1):2-7. PubMed ID: 10942966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.